ArticleJAAD international2026
Digital psychotherapeutic interventions to reduce dermatological symptom burden: Development and testing of MindMySkin.
Article in JAAD international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Economic Evaluation of a Digital Psychobehavioral Intervention for Chronic Inflammatory Skin Disease (MindMySkin): Protocol for a Trial-Based Cost-Effectiveness Analysis.JMIR research protocols · 2026Article
- Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although cognitive and behavioral factors significantly impact dermatological outcomes, psychobehavioral interventions remain inaccessible and underused. Objective: To develop and test a psychobehavioral intervention (MindMySkin) delivered via a mobile application. Methods: Needs assessment, evidence-based module development, and formative user-centered evaluation were conducted in participants with eczema, psoriasis, or chronic urticaria. The developed prototype modules were further iteratively refined following additional qualitative and quantitative feedback. Results: 27 participants contributed to 24 1:1 interviews and 231 responses between June 2023 and November 2024. Modules were highly rated (median score 4 or 5/5) for utility, interest, understandability, and recommendation for inclusion, underscoring strong acceptability. Participants valued the informative content and conversational tone but highlighted skepticism toward reflection exercises and oversimplification of patient difficulties. Design challenges include balancing time demanding but effective modules with shorter more appealing content. The final intervention comprised 74 modules addressing illness coherence, symptom management, functional impairment, emotional impairment, and the patient-physician relationship. Limitations: No participant reviewed the full program and modules were assigned, limiting insights on voluntary adherence. Conclusion: This study establishes the unmet need for psychotherapeutic support and demonstrates the acceptability, appropriateness, and usability of a self-administered psychobehavioral intervention in improving dermatological care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.